GENLISA™ Human SARS-CoV-2 (Covid-19) Spike RBD Omicron Variant (B.1.1.529) Antigen Quantitative TITRATION ELISA
ELISA for the quantitative detection of SARS-CoV-2 spike protein RBD of the Omicron Variant (B.1.1.529) in human serum and plasma samples. Lead time is 2 - 3 weeks. IFU / Datasheet coming soon.
Read more
€0.00
(tax incl.)
Reference:
KBVH015-48
Brand: